dr. tannir on the combination of sunitinib and temsirolimus for metastatic renal cell carcinoma
Published 10 years ago • 827 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
1:34
dr. tannir discusses sunitinib in combination with temsirolimus for mrcc
-
0:40
dr. robert dreicer on an alternate sunitinib schedule in metastatic renal cell carcinoma
-
47:21
critical advances in immunotherapy for kidney cancer, with nizar tannir
-
5:09
comparz trial and alternate sunitinib dosing schedule in metastatic renal cell carcinoma
-
7:54
combination therapies in renal cell carcinoma
-
8:42
immunotherapy: the path to a cancer cure (for clinicians)
-
56:59
renal cell carcinoma
-
3:55
my fight against kidney cancer - pat's story - apr 10, 2010
-
7:15
introduction: multidisciplinary frontline treatment of metastatic renal cell carcinoma
-
7:34
frontline sunitinib compared to everolimus in metastatic renal cell carcinoma
-
6:57
dosing schedule of sunitinib in renal cell carcinoma
-
0:51
dr. schmidinger on managing side effects from targeted therapies in rcc
-
7:14
dosing sunitinib and pazopanib in renal cell carcinoma
-
27:50
systemic therapy for metastatic non-clear cell rcc: are there any good options?
-
8:43
optimizing the upfront treatment of metastatic renal cell carcinoma
-
5:31
newly diagnosed metastatic renal cell carcinoma
-
1:23
dr. lara on the role of sunitinib for renal cell carcinoma
-
2:23
s-trac phase iii trial of sunitinib as adjuvant therapy in high-risk renal cell cancer patients
-
1:20
dr. choueiri on overall findings of cabosun trial for rcc
-
2:13
treating advanced renal-cell carcinoma
-
2:02
dr. mcgregor on implications of the fda approval of pembrolizumab/axitinib in rcc
-
26:50
management of toxicities related to systemic therapy for metastatic renal cell carcinoma